| Authors: |
Marina CL; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil. clara.marina@unb.br., Greuel AM; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil., Las-Casas LO; Carlos Chagas Institute, Oswaldo Cruz Foundation, Curitiba, Paraná, Brazil., Lopes-Gomes E; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil., Romero Ferrari SSA; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil., Rodrigues ML; Carlos Chagas Institute, Oswaldo Cruz Foundation, Curitiba, Paraná, Brazil.; Instituto de Microbiologia Paulo de Goes, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Centre for Medical Mycology in Latin America (CMM LATAM) Unit, São Paulo, Brazil., Dos Reis FCG; Carlos Chagas Institute, Oswaldo Cruz Foundation, Curitiba, Paraná, Brazil., Bocca AL; Bi-Institutional Platform for Translational Medicine, Oswaldo Cruz Foundation, Ribeirão Preto, São Paulo, Brazil.; National Institute of Science and Technology in Human Pathogenic Fungi, Ribeirão Preto, São Paulo, Brazil.; Molecular Biotechnology Center, University of Brasilia, Brasília, Federal District, Brazil., Titze-de-Almeida SS; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil., Resende FFB; University Center of the Central Highlands Apparecido dos Santos (UNICEPLAC), Gama, Brasília, Federal District, Brazil., de Sant'Ana FJF; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil., Titze-de-Almeida R; Technology for Gene Therapy Lab., University of Brasília, Brasília, Federal District, Brazil. |
